FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis

The fibroblast growth factor-4 receptor (FGFR4) is a member of receptor tyrosine kinase. The FGFR4 Gly388Arg polymorphism in the transmembrane domain of the receptor has been shown to increase genetic susceptibility to cancers. However, its prognostic impact in cancer patients still remains controve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Han, Jeong, Soo Young, Jang, Hyun Joo, Park, Sung Taek, Kim, Hyeong Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560792/
https://www.ncbi.nlm.nih.gov/pubmed/34737965
http://dx.doi.org/10.3389/fonc.2021.762528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560792/
https://www.ncbi.nlm.nih.gov/pubmed/34737965
http://dx.doi.org/10.3389/fonc.2021.762528

Ejemplares similares